99% Original Powder Finasteride CAS 98319-26-7 with Safe Delivery

Melting point 253 °C
alpha 405 -59° (c = 1 in methanol)
Boiling point 576.6±50.0 °C(Predicted)
density 1.065±0.06 g/cm3(Predicted)
storage temp. room temp
solubility DMSO: 32 mg/mL, soluble
pka 14.17±0.70(Predicted)
form solid
color white to beige
Water Solubility insoluble


Product Name: Finasteride
Synonyms: (5alpha,17beta)-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;17beta-(n-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5-alpha,17-be;4-azaandrost-1-ene-17-carboxamide,n-(1,1-dimethylethyl)-3-oxo-,(5alpha,17beta;l-652,931;mk-0906;n-tert-butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide;(5alpha,17beta)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
CAS: 98319-26-7
MF: C23H36N2O2
MW: 372.54
EINECS: 620-534-3
Product Categories: Hormone Drugs;Biochemistry;Steroids;Steroids (Others);Intermediates & Fine Chemicals;Vitamin Ingredients;Active Pharmaceutical Ingredients;API;Pharmaceuticals;Intracellular receptor;Steroid and Hormone;PROSCAR
Mol File: 98319-26-7.mol

Uses:

1.Treatment of benign prostatic hyperplasia and androgenetic alopecia

2.Finasteride is indicated for use in men only.

Women of childbearing age cannot take finasteride because it may cause hypospadia (a developmental abnormality of the penis) in the male offspring if taken during pregnancy.

3.An aza-steroid that is a synthetic drug for the treatment of benign prostatic hyperplasia.